Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by the combination of Coriolus versicolor and Ganoderma lucidum

Hsieh,Tze-Chen; Wu,Joseph  M.

doi:10.3892/ijmm.2013.1378

Regulation of cell cycle transition and induction of apoptosis in HL-60 leukemia cells by the combination of Coriolus versicolor and Ganoderma lucidum

Authors:
- Tze-Chen Hsieh
- Joseph M. Wu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, NY 10595, USA
Published online on: May 10, 2013 https://doi.org/10.3892/ijmm.2013.1378
Pages: 251-257

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Medicinal mushrooms have served as the mainstay of treatment for a variety of human illnesses in Asian countries, mostly as supplements by cancer patients. Extracts prepared from Trametes versicolor under the trade name of I'm-Yunity exhibit anti-tumorigenic activities, as supported by inhibition of the proliferation and induction of apoptosis in malignant cells. Similar effects have also been observed for the Reishi mushroom Ganoderma lucidum. The two mushrooms exert their medicinal activities primarily through a family of polysaccharo-peptides. Despite the common identity in their bioactive ingredients, whether their combination might elicit an expanded efficacy and mechanism has not been investigated. In the present study, we investigated similarities and differences between extracts prepared from I'm-Yunity and from a formulation denoted I'm-Yunity-Too combining I'm-Yunity and Ganoderma lucidum. By assaying their anti-proliferative and anti-apoptotic effects using human promyelocytic HL-60 cells, we found that the ethanolic extract of I'm-Yunity-Too was more active in inducing cell death compared to I'm-Yunity, based on measured changes in the expression of caspase 3 and Bax. Moreover, ethanolic extracts of I'm-Yunity-Too exhibited more potent activity compared to its aqueous extracts with regard to suppression of the growth and induction of apoptosis, as assayed by the more pronounced downregulation of phosphorylation of Rb and increased cleavage of poly(ADP‑ribose) polymerase (PARP) from its native 112-kDa form to the inactive 89-kDa product. These results suggested that the chemopreventive potential of I'm-Yunity may be enhanced by adding Ganoderma lucidum and that their bioactive ingredients potentially exhibit mechanistic synergism suggesting a more efficacious adjunct in chemotherapy.

View Figures

View References

1.	Doll R and Peto R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst. 66:1191–1308. 1981.PubMed/NCBI
2.	Steinmetz KA and Potter JD: Vegetables, fruit, and cancer. I Epidemiology Cancer Causes Control. 2:325–357. 1991. View Article : Google Scholar
3.	Steinmetz KA and Potter JD: Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc. 96:1027–1039. 1996. View Article : Google Scholar : PubMed/NCBI
4.	Willett WC: Diet, nutrition, and avoidable cancer. Environ Health Perspect. 103(Suppl 8): 165–170. 1995. View Article : Google Scholar : PubMed/NCBI
5.	Link LB and Potter JD: Raw versus cooked vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev. 13:1422–1435. 2004.PubMed/NCBI
6.	Potter JD: Vegetables, fruit, and cancer. Lancet. 366:527–530. 2005. View Article : Google Scholar : PubMed/NCBI
7.	Surh YJ: Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP and Gescher AJ: Dietary polyphenolic phytochemicals - promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer. 120:451–458. 2007. View Article : Google Scholar
9.	de Kok TM, van Breda SG and Manson MM: Mechanisms of combined action of different chemopreventive dietary compounds: a review. Eur J Nutr. 47(Suppl 2): 51–59. 2008.PubMed/NCBI
10.	Link A, Balaguer F and Goel A: Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol. 80:1771–1792. 2010. View Article : Google Scholar : PubMed/NCBI
11.	Lee KW, Bode AM and Dong Z: Molecular targets of phytochemicals for cancer prevention. Nat Rev Cancer. 11:211–218. 2011. View Article : Google Scholar : PubMed/NCBI
12.	Sliva D: Ganoderma lucidum (Reishi) in cancer treatment. Integr Cancer Ther. 2:358–364. 2003. View Article : Google Scholar
13.	Yuen JW and Gohel MD: Anticancer effects of Ganoderma lucidum: a review of scientific evidence. Nutr Cancer. 53:11–17. 2005.
14.	Paterson RR: Ganoderma - a therapeutic fungal biofactory. Phytochemistry. 67:1985–2001. 2006. View Article : Google Scholar : PubMed/NCBI
15.	Zhou X, Lin J, Yin Y, Zhao J, Sun X and Tang K: Ganodermataceae: natural products and their related pharmacological functions. Am J Chin Med. 35:559–574. 2007. View Article : Google Scholar : PubMed/NCBI
16.	Zhong JJ and Xiao JH: Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. Adv Biochem Eng Biotechnol. 113:79–150. 2009.PubMed/NCBI
17.	Zhang J, Tang Q, Zhou C, et al: GLIS, a bioactive proteoglycan fraction from Ganoderma lucidum, displays anti-tumour activity by increasing both humoral and cellular immune response. Life Sci. 87:628–637. 2010.PubMed/NCBI
18.	Wasser SP and Weis AL: Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 19:65–96. 1999.PubMed/NCBI
19.	Cui J and Chisti Y: Polysaccharopeptides of Coriolus versicolor: physiological activity, uses, and production. Biotechnol Adv. 21:109–122. 2003.
20.	Kidd PM: The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 5:4–27. 2000.PubMed/NCBI
21.	Ho CY, Kim CF, Leung KN, et al: Coriolus versicolor (Yunzhi) extract attenuates growth of human leukemia xenografts and induces apoptosis through the mitochondrial pathway. Oncol Rep. 16:609–616. 2006.
22.	Nicandro JP, Tsourounis C, Frassetto L and Guglielmo BJ: In vivo effect of I’m-Yunity on hepatic cytochrome P450 3A4. J Herb Pharmacother. 7:39–56. 2007.
23.	Hui KP, Sit WH and Wan JM: Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle-dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells. Oncol Rep. 14:145–155. 2005.PubMed/NCBI
24.	Hsieh TC, Kunicki J, Darzynkiewicz Z and Wu JM: Effects of extracts of Coriolus versicolor (I’m-Yunity) on cell-cycle progression and expression of interleukins-1 beta, -6, and -8 in promyelocytic HL-60 leukemic cells and mitogenically stimulated and nonstimulated human lymphocytes. J Altern Complement Med. 8:591–602. 2002.PubMed/NCBI
25.	Zeng F, Hon CC, Sit WH, et al: Molecular characterization of Coriolus versicolor PSP-induced apoptosis in human promyelotic leukemic HL-60 cells using cDNA microarray. Int J Oncol. 27:513–523. 2005.
26.	Hsieh TC, Wu P, Park S and Wu JM: Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extra-cellular signaling regulatory protein expression by water extracts of I’m-Yunity (PSP). BMC Complement Altern Med. 6:302006.PubMed/NCBI
27.	Hsieh TC and Wu JM: Differential control of growth, cell cycle progression, and gene expression in human estrogen receptor positive MCF-7 breast cancer cells by extracts derived from polysaccharopeptide I’m-Yunity and Danshen and their combination. Int J Oncol. 29:1215–1222. 2006.PubMed/NCBI
28.	Hu H, Ahn NS, Yang X, Lee YS and Kang KS: Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer. 102:250–253. 2002. View Article : Google Scholar
29.	Tsang KW, Lam CL, Yan C, et al: Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer. Respir Med. 97:618–624. 2003. View Article : Google Scholar
30.	Wong CK, Bao YX, Wong EL, Leung PC, Fung KP and Lam CW: Immunomodulatory activities of Yunzhi and Danshen in post-treatment breast cancer patients. Am J Chin Med. 33:381–395. 2005. View Article : Google Scholar : PubMed/NCBI
31.	Wan JM, Sit WH and Louie JC: Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30. Int J Oncol. 32:689–699. 2008.PubMed/NCBI
32.	Luk SU, Lee TK, Liu J, et al: Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population. PLoS One. 6:e198042011. View Article : Google Scholar : PubMed/NCBI
33.	Jiang J, Slivova V, Harvey K, Valachovicova T and Sliva D: Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-kappaB signaling. Nutr Cancer. 49:209–216. 2004. View Article : Google Scholar
34.	Yue GG, Fung KP, Tse GM, Leung PC and Lau CB: Comparative studies of various ganoderma species and their different parts with regard to their antitumor and immunomodulating activities in vitro. J Altern Complement Med. 12:777–789. 2006. View Article : Google Scholar : PubMed/NCBI
35.	Jiang J, Grieb B, Thyagarajan A and Sliva D: Ganoderic acids suppress growth and invasive behavior of breast cancer cells by modulating AP-1 and NF-κB signaling. Int J Mol Med. 21:577–584. 2008.PubMed/NCBI
36.	Weng CJ, Chau CF, Yen GC, Liao JW, Chen DH and Chen KD: Inhibitory effects of Ganoderma lucidum on tumorigenesis and metastasis of human hepatoma cells in cells and animal models. J Agric Food Chem. 57:5049–5057. 2009.PubMed/NCBI
37.	Thyagarajan A, Jedinak A, Nguyen H, et al: Triterpenes from Ganoderma lucidum induce autophagy in colon cancer through the inhibition of p38 mitogen-activated kinase (p38 MAPK). Nutr Cancer. 62:630–640. 2010.
38.	Hsieh TC and Wu JM: Suppression of proliferation and oxidative stress by extracts of Ganoderma lucidum in the ovarian cancer cell line OVCAR-3. Int J Mol Med. 28:1065–1069. 2011.PubMed/NCBI
39.	Wu G, Qian Z, Guo J, et al: Ganoderma lucidum extract induces G1 cell cycle arrest, and apoptosis in human breast cancer cells. Am J Chin Med. 40:631–642. 2012. View Article : Google Scholar
40.	Bao PP, Lu W, Cui Y, et al: Ginseng and Ganoderma lucidum use after breast cancer diagnosis and quality of life: a report from the Shanghai Breast Cancer Survival Study. PLoS One. 7:e393432012.PubMed/NCBI
41.	DiPietrantonio AM, Hsieh TC, Olson SC and Wu JM: Regulation of G1/S transition and induction of apoptosis in HL-60 leukemia cells by fenretinide (4HPR). Int J Cancer. 78:53–61. 1998. View Article : Google Scholar : PubMed/NCBI
42.	DiPietrantonio AM, Hsieh TC, Juan G, Traganos F, Darzynkiewicz Z and Wu JM: Fenretinide-induced caspase 3 activity involves increased protein stability in a mechanism distinct from reactive oxygen species elevation. Cancer Res. 60:4331–4335. 2000.
43.	Elangovan S and Hsieh TC: Control of cellular redox status and upregulation of quinone reductase NQO1 via Nrf2 activation by α-lipoic acid in human leukemia HL-60 cells. Int J Oncol. 33:833–838. 2008.PubMed/NCBI
44.	Bedner E, Burfeind P, Hsieh TC, et al: Cell cycle effects and induction of apoptosis caused by infection of HL-60 cells with human granulocytic ehrlichiosis pathogen measured by flow and laser scanning cytometry. Cytometry. 33:47–55. 1998. View Article : Google Scholar
45.	Smolewski P, Bedner E, Du L, et al: Detection of caspases activation by fluorochrome-labeled inhibitors: multiparameter analysis by laser scanning cytometry. Cytometry. 44:73–82. 2001. View Article : Google Scholar : PubMed/NCBI
46.	Hsieh TC, Aguero-Rosenfeld ME, Wu JM, et al: Cellular changes and induction of apoptosis in human promyelocytic HL-60 cells infected with the agent of human granulocytic ehrlichiosis (HGE). Biochem Biophys Res Commun. 232:298–303. 1997. View Article : Google Scholar : PubMed/NCBI
47.	Hsieh TC, Yang CJ, Lin CY, Lee YS and Wu JM: Control of stability of cyclin D1 by quinone reductase 2 in CWR22Rv1 prostate cancer cells. Carcinogenesis. 33:670–677. 2012. View Article : Google Scholar : PubMed/NCBI
48.	Yang CJ, Lin CY, Hsieh TC, Olson SC and Wu JM: Control of eotaxin-1 expression and release by resveratrol and its metabolites in culture human pulmonary artery endothelial cells. Am J Cardiovasc Dis. 1:16–30. 2011.PubMed/NCBI
49.	Hsieh TC: Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells. Asian J Androl. 11:653–661. 2009. View Article : Google Scholar : PubMed/NCBI
50.	Hsieh TC: Antiproliferative effects of resveratrol and the mediating role of resveratrol targeting protein NQO2 in androgen receptor-positive, hormone-non-responsive CWR22Rv1 cells. Anticancer Res. 29:3011–3017. 2009.PubMed/NCBI
51.	Lin CN, Tome WP and Won SJ: Novel cytotoxic principles of Formosan Ganoderma lucidum. J Nat Prod. 54:998–1002. 1991. View Article : Google Scholar : PubMed/NCBI